• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Remedy Entertainment Oyj: Remedy Entertainment Plc: Remedy announces sales information for Alan Wake 2

REMEDYRegulatory press release16.02.2024 klo 09.00
Discuss
Read the release

Remedy Entertainment PlcStock Exchange Release         February 16, 2024 at 9:00 a.m. EET

Remedy announces sales information for Alan Wake 2

Alan Wake 2 was released in October 2023 to worldwide critical acclaim, earning a Metacritic score of 89 at launch. Today, Remedy Entertainment Plc ("Remedy") announces that Alan Wake 2 has sold 1 million units by the end of December 2023, and 1.3 million units as of the beginning of February 2024. Alan Wake 2 is Remedy's fastest selling game so far.

By comparison, Alan Wake 2 sold over 50% more copies and over three times more digital copies in its first two months than Control did in its first four months. Since its release in 2019, Control has sold over 4 million units, generating net revenue (shareable revenue between Remedy and a publishing partner, excluding taxes and platform fees) of approximately EUR 100 million. A great game can generate excellent long tail sales, and we expect this to be the case with Alan Wake 2 as well.

We will continue promoting and supporting Alan Wake 2 and are creating two paid DLCs that will expand the story. We are also releasing updates and carrying out other activities to support the game and its community.

Remedy's CEO Tero Virtala commented: "We are happy with the start of Alan Wake 2's sales. The price point has also remained at a high level, and the game has already recouped a significant part of the development and marketing expenses. We will continue to develop the game to serve existing fans and attract new players and expect the game to continue selling well." Tero Virtala continued: "The successful launch of Alan Wake 2 has supported our other game projects: Condor, Control 2 and Max Payne 1&2 remake have all increased development pace thanks to the personnel released from Alan Wake 2, and we expect these projects to reach their next development stages during the first half of 2024. We now have two established franchises: Control and Alan Wake, which are linked through the Remedy Connected Universe. Growing and expanding these franchises will be a key part of our future."  

REMEDY ENTERTAINMENT PLC

More information
Tero Virtala, CEO 
Phone: +358 9 435 5040  
Email: tero.virtala@remedygames.com

Veli-Pekka Puolakanaho, Head of Corporate Development and IR 
Phone: +358 50 430 0936 
Email: veli-pekka.puolakanaho@remedygames.com

Remedy in brief

Remedy Entertainment Plc is a pioneering, globally renowned video game company founded in 1995 and headquartered in Finland with an office in Stockholm, Sweden. Known for its story-driven and visually stunning action games, Remedy has created multiple successful, critically acclaimed franchises such as Alan Wake, Control, and Max Payne. Remedy also develops its own Northlight® game engine and tools technology that powers many of its games. Remedy's shares are listed on Nasdaq Helsinki's official list.  

www.remedygames.com